Question

A 68-year-old man with type 2 diabetes and established atherosclerotic cardiovascular disease has HbA1c 7.4% on maximally tolerated metformin. According to Diabetes Canada, which additional agent is preferred to reduce cardiovascular risk?

Accepted Answer

Add an SGLT2 inhibitor or GLP-1 receptor agonist with proven CV benefit

Answer

Add a sulfonylurea

Answer

Add a DPP-4 inhibitor

Answer

Add acarbose

Answer

Switch metformin to basal insulin only

Practice question

A 68-year-old man with type 2 diabetes and established atherosclerotic cardiovascular disease has HbA1c 7.4% on maximally tolerated metformin. According to Diabetes Canada, which additional agent is preferred to reduce cardiovascular risk?